COSM (Cosmos Health) Other Financing: $3.53 Mil (TTM As of Mar. 2026)


COSM Cosmos Health Inc COSM
24 GF Score
Price $0.19
GF Value $0.36
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Cosmos Health Other Financing?

Cosmos Health COSM +0.27% 24 Other Financing is $3.53 Mil as of Mar. 2026. GuruFocus rates COSM with a GF Score™ of 24/100 and a GF Value™ of $0.36 (Possible Value Trap). The stock has 6 warning signs investors should review.

Cosmos Health's Other Financing for the three months ended in Mar. 2026 was $-0.06 Mil.

Cosmos Health's Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 was $3.53 Mil.

Cosmos Health Other Financing Historical Data

* Premium members only.

The historical data trend for Cosmos Health's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmos Health Other Financing Chart

Cosmos Health Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 7.63 2.82 3.85 -1.83

Cosmos Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.18 -0.49 4.26 -0.06
COSM
24GF Score
Cosmos Health Inc COSM
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cosmos Health Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $3.53 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $3.53 Mil mean?
Cosmos Health (COSM) has a Other Financing of $3.53 Mil as of Mar. 2026. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Cosmos Health and its competitors.
Is Cosmos Health's Other Financing too high?
Cosmos Health's current Other Financing is $3.53 Mil. Overall, Cosmos Health has a GF Score™ of 24/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Cosmos Health's Other Financing compare to HKPD and VNOV?
Cosmos Health's Other Financing of $3.53 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Medical Distribution company?
A good Other Financing depends on the Medical Distribution industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Cosmos Health and its competitors. Cosmos Health's current Other Financing is $3.53 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmos Health stock overvalued right now?
Based on GuruFocus' analysis, Cosmos Health (COSM) is currently considered Possible Value Trap. The stock's GF Value™ is $0.36, compared to a current price of $0.19 — trading 48.4% below its estimated fair value. The current Other Financing is $3.53 Mil. Cosmos Health's overall GF Score™ is 24/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Cosmos Health (COSM), the current Other Financing is $3.53 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmos Health (COSM) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmos Health stock appears to be undervalued. The current stock price of $0.19 is trading 48.4% below its estimated GF Value™ of $0.36. GuruFocus considers Cosmos Health to be Possible Value Trap.

Key valuation signals for COSM:

  • Other Financing: $3.53 Mil
  • GF Value™: $0.36 vs. price of $0.19 (48.4% below fair value)
  • GF Score™: 24/100 with 6 warning signs

No single metric tells the full story. See the COSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmos Health Business Description

Other Exchanges V67A:Germany
Address 5 Agiou Georgiou Street, Pilea, Thessaloniki, GRC, 55438
Cosmos Health Inc is a diversified, vertically integrated healthcare group, owner of proprietary pharmaceutical and nutraceutical brands, generics, manufacturer and distributor of healthcare products, engaged in research & development of medicines and repurposing drugs as well as operator of a telehealth platform. The company has developed its own proprietary branded nutraceutical products, named 'Sky Premium Life' and 'Mediterranation'. Its product portfolio includes generics and over-the-counter pharmaceutical products, medicines, as well as nutraceuticals and biocides. The company's Reportable segments are Wholesale, Pharma manufacturing, and Nutraceutical and pharmaceuticals, with the majority of revenue generated from the Wholesale segment.
24GF Score

Get the complete analysis for COSM

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.19
Price
$0.36
GF Value